Application Note
High Sensitivity Assay Development on the LSA®
Application Note
Immunoassay Development using HT-SPR at Bio-Techne
Application Note
NiHC200M Biosensor Kinetic Assays on the Carterra® LSA®
Application Note
Quantitation of IgG and His-tagged proteins using the Carterra LSA
Brochure
Carterra Brochure: Disruptive Drug Discovery Platforms for Screening and Characterization
Webinar
Characterization of Ion Channel Activity Blocking mAbs with High Throughput SPR – April 24, 2018
Learn how Tetragenetics has developed a strategy to generate and identify monoclonal antibodies targeting ion channels based on high-level expression of recombinant channels in Tetrahymena thermophila, enabling the development of potent immunogens and tools that allow deep mining of the immune repertoire.
Carterra’s LSA can analyze up to 384 binding interactions simultaneously, providing mAb characterization throughput to match the output of the current generation of mAb expression platforms; all antibodies can be rapidly and comprehensively screened so that unique epitopes and potential novel therapeutic candidates are not missed, while expanding IP coverage.
Speakers:
Paul Colussi, PhD, Vice President, Research, TetraGenetics
Yasmina Noubia Abdiche, PhD, Chief Scientific Officer, Carterra